Whyze Health is excited to announce its participation in Mayo Clinic Platform_Accelerate, a groundbreaking 30-week program designed to help early-stage health tech AI startups get market-ready. Through this program, Whyze Health will work closely with Mayo Clinic’s world-renowned experts to further advance its cutting-edge AI-driven health platform.
“Joining Mayo Clinic Platform_Accelerate marks a significant milestone in our journey,” said Frances Abeton, CEO at Whyze Health. “This collaboration will help us refine our AI platform and expand our AI capabilities in support of our goal to transform patient care globally.”
Throughout the Accelerate program, Whyze Health will focus on enhancing its AI-driven health platform with a disciplined approach to model evaluation and clinical readiness. The goal is to create a seamless healthcare experience that significantly improves patient outcomes.
As an Accelerate participant, Whyze Health will benefit from access to Mayo Clinic’s rich, de-identified data sets, enabling the team to gain meaningful insights that will further refine the platform’s AI capabilities. Additionally, the program offers the use of Mayo Clinic Platform’s advanced products and services to support model evaluation, validation and improvement.
Guided by leaders across regulatory, clinical, technology, and business domains through curated educational sessions, Whyze Health will receive personalised mentorship from a clinical expert throughout the 30-week journey, maximising the potential for success.
Stay connected with Whyze Health’s journey throughout the Mayo Clinic Platform_Accelerate program by following us on LinkedIn. We’ll be sharing updates, insights, and key milestones as we continue to innovate and drive healthcare transformation. Don’t miss out—join our LinkedIn community today!
Mayo Clinic has a financial interest in the technology referenced in this press release. Mayo Clinic will use any revenue it receives to support its not-for-profit mission in patient care, education, and research.